NO20025590D0 - Fenylglycin-derivater - Google Patents

Fenylglycin-derivater

Info

Publication number
NO20025590D0
NO20025590D0 NO20025590A NO20025590A NO20025590D0 NO 20025590 D0 NO20025590 D0 NO 20025590D0 NO 20025590 A NO20025590 A NO 20025590A NO 20025590 A NO20025590 A NO 20025590A NO 20025590 D0 NO20025590 D0 NO 20025590D0
Authority
NO
Norway
Prior art keywords
phenylglycine derivatives
physiologically acceptable
derivatives
phenylglycine
carbamimidoyl
Prior art date
Application number
NO20025590A
Other languages
English (en)
Other versions
NO20025590L (no
Inventor
Leo Alig
Katrin Groebke Zbinden
Kurt Hilpert
Holger Kuehne
Ulrike Obst
Hans Peter Wessel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20025590D0 publication Critical patent/NO20025590D0/no
Publication of NO20025590L publication Critical patent/NO20025590L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C07D317/36—Alkylene carbonates; Substituted alkylene carbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
NO20025590A 2000-05-23 2002-11-21 Fenylglycin-derivater NO20025590L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00110881 2000-05-23
PCT/EP2001/005633 WO2001090051A1 (en) 2000-05-23 2001-05-17 Phenylglycine derivatives

Publications (2)

Publication Number Publication Date
NO20025590D0 true NO20025590D0 (no) 2002-11-21
NO20025590L NO20025590L (no) 2002-11-21

Family

ID=8168800

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025590A NO20025590L (no) 2000-05-23 2002-11-21 Fenylglycin-derivater

Country Status (23)

Country Link
US (1) US6548694B2 (no)
EP (1) EP1289939A1 (no)
JP (1) JP3842132B2 (no)
KR (1) KR100569517B1 (no)
CN (1) CN1305839C (no)
AR (1) AR028596A1 (no)
AU (2) AU8177401A (no)
BR (1) BR0110998A (no)
CA (1) CA2408602C (no)
EC (1) ECSP024360A (no)
HU (1) HUP0302073A2 (no)
IL (1) IL152581A0 (no)
MA (1) MA26905A1 (no)
MX (1) MXPA02011466A (no)
NO (1) NO20025590L (no)
NZ (1) NZ522412A (no)
PE (1) PE20011314A1 (no)
PL (1) PL361355A1 (no)
RU (1) RU2268257C2 (no)
UY (1) UY26721A1 (no)
WO (1) WO2001090051A1 (no)
YU (1) YU83602A (no)
ZA (1) ZA200208899B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU758229B2 (en) * 1998-12-14 2003-03-20 F. Hoffmann-La Roche Ag Phenylglycine derivatives
DE10300049A1 (de) * 2003-01-03 2004-07-15 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Faktor VIIa inhibieren
US6642386B2 (en) 2002-02-06 2003-11-04 Hoffmann-La Roche Inc. N-(4-carbamimidoyl-phenyl)-glycine derivatives
GB0211931D0 (en) * 2002-05-23 2002-07-03 Univ Liverpool Methods & device utilizing adsorption of molecules at a surface or interface
TW200410921A (en) * 2002-11-25 2004-07-01 Hoffmann La Roche Mandelic acid derivatives
WO2004072101A2 (en) 2003-02-11 2004-08-26 Bristol-Myers Squibb Company Phenylglycine derivatives useful as serine protease inhibitors
WO2004072102A2 (en) 2003-02-11 2004-08-26 Bristol-Myers Squibb Company Benzene acetamide compounds useful as serine protease inhibitors
DE10306202A1 (de) 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
US7917130B1 (en) 2003-03-21 2011-03-29 Stratosaudio, Inc. Broadcast response method and system
US7776804B2 (en) * 2005-03-16 2010-08-17 The Lubrizol Corporation Viscosity improver compositions providing improved low temperature characteristics to lubricating oil
US7056932B2 (en) * 2003-12-19 2006-06-06 Hoffman-La Roche Inc. Heterocyclyl substituted 1-alkoxy acetic acid amides
WO2006041119A1 (ja) * 2004-10-13 2006-04-20 Eisai R & D Management Co., Ltd. ヒドラジド誘導体
EP1838296B1 (en) * 2004-10-20 2012-08-08 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
ES2349428T3 (es) 2005-01-10 2011-01-03 Bristol-Myers Squibb Company Derivados de fenilglicinamida útiles como anticoagulantes.
WO2007002313A2 (en) * 2005-06-24 2007-01-04 Bristol-Myers Squibb Company Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
WO2007103996A1 (en) * 2006-03-09 2007-09-13 Bristol-Myers Squibb Company 2-(aryloxy)acetamide factor viia inhibitors useful as anticoagulants
DE602007011231D1 (de) * 2006-03-24 2011-01-27 Eisai R&D Man Co Ltd Triazolonderivat
US7855194B2 (en) 2006-03-27 2010-12-21 Hoffmann-La Roche Inc. Pyrimidine, quinazoline, pteridine and triazine derivatives
JP5236664B2 (ja) 2007-02-01 2013-07-17 レスバーロジックス コーポレイション 心血管疾患を予防および治療するための化合物
EP1967522A1 (en) * 2007-03-07 2008-09-10 Novo Nordisk A/S New blood coagulation factor inhibitors
EP2202231A4 (en) * 2007-09-21 2011-09-28 Eisai R&D Man Co Ltd 2,3-DIHYDROIMINOISOINDOLE DERIVATIVE
US8631448B2 (en) 2007-12-14 2014-01-14 Stratosaudio, Inc. Systems and methods for scheduling interactive media and events
AU2009262252B2 (en) * 2008-06-26 2013-05-02 Resverlogix Corp. Methods of preparing quinazolinone derivatives
JP5635535B2 (ja) 2009-01-08 2014-12-03 レスバーロジックス コーポレイション 心血管疾患の予防および治療のための化合物
NZ595747A (en) 2009-03-18 2015-06-26 Resverlogix Corp Novel quinazolinones and related compounds for use as anti-inflammatory agents
DK2421533T3 (en) 2009-04-22 2019-01-07 Resverlogix Corp Hitherto unknown anti-inflammatory agents
CN102887836B (zh) * 2011-07-18 2014-03-26 西南大学 L-苯甘氨酸衍生物及其应用
CN103945848B (zh) 2011-11-01 2016-09-07 雷斯韦洛吉克斯公司 被取代的喹唑啉酮的口服即释制剂
GB201118876D0 (en) * 2011-11-01 2011-12-14 Astex Therapeutics Ltd Pharmaceutical compounds
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
CN105073744B (zh) 2012-12-21 2019-11-08 齐尼思表观遗传学有限公司 作为溴结构域抑制剂的新型杂环化合物
CN107530356A (zh) 2015-03-13 2018-01-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法
CN111072562B (zh) * 2019-11-07 2021-12-07 中山大学 一种四氢异喹啉衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2201396T3 (es) 1997-12-04 2004-03-16 F. Hoffmann-La Roche Ag Derivados de la n - (4-carbamimido-fenil) -glicinamida.
AU2300699A (en) 1998-02-17 1999-08-30 Ono Pharmaceutical Co. Ltd. Amidino derivatives and drugs containing the same as the active ingredient
AU758229B2 (en) * 1998-12-14 2003-03-20 F. Hoffmann-La Roche Ag Phenylglycine derivatives

Also Published As

Publication number Publication date
JP3842132B2 (ja) 2006-11-08
WO2001090051A1 (en) 2001-11-29
MXPA02011466A (es) 2003-04-25
CN1305839C (zh) 2007-03-21
ZA200208899B (en) 2004-02-19
CN1430599A (zh) 2003-07-16
KR100569517B1 (ko) 2006-04-07
YU83602A (sh) 2006-05-25
EP1289939A1 (en) 2003-03-12
HUP0302073A2 (hu) 2003-09-29
PL361355A1 (en) 2004-10-04
IL152581A0 (en) 2003-05-29
JP2003534311A (ja) 2003-11-18
AU8177401A (en) 2001-12-03
NZ522412A (en) 2004-05-28
AR028596A1 (es) 2003-05-14
CA2408602A1 (en) 2001-11-29
UY26721A1 (es) 2001-12-28
RU2268257C2 (ru) 2006-01-20
PE20011314A1 (es) 2002-01-04
KR20030007678A (ko) 2003-01-23
CA2408602C (en) 2008-01-08
MA26905A1 (fr) 2004-12-20
AU2001281774B2 (en) 2005-03-10
US20020004608A1 (en) 2002-01-10
BR0110998A (pt) 2003-04-08
NO20025590L (no) 2002-11-21
US6548694B2 (en) 2003-04-15
ECSP024360A (es) 2003-03-31

Similar Documents

Publication Publication Date Title
NO20025590D0 (no) Fenylglycin-derivater
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
ATE302775T1 (de) Carbolinderivate
PT1204323E (pt) Fungicidas
DE60236102D1 (en) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
ATE346067T1 (de) Carbolinderivate
MXPA05010000A (es) Derivados de p-diaminobenceno substituidos.
HK1045990A1 (en) Novel derivatives and analogues of galanthamin.
DE60112960D1 (de) Kondensierte pyridoindolderivate
MXPA05009282A (es) Derivados de anilina sustituidos.
ATE259813T1 (de) Triazolopyrimidinderivate
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
PT1204659E (pt) Benzofuranos serotoninergicos
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
EA200600456A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
ATE344272T1 (de) Uridinderivate als antibiotika
IS8034A (is) Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla
EA200600454A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
TR200100475T2 (tr) N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları.
EA200600250A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
DK1358182T3 (da) Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer
SG145574A1 (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application